share_log

Rosenblatt Maintains Neutral on Adtran, Raises Price Target to $8

Benzinga ·  Dec 15, 2023 07:51

Rosenblatt analyst Mike Genovese maintains Adtran (NASDAQ:ADTN) with a Neutral and raises the price target from $7 to $8.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment